About
Dr. Dalia Rivenzon-Segal is a partner and patent attorney in the Life Science and Chemistry practice at Reinhold Cohn & Partners, handling drafting and prosecution of patent applications, freedom-to-operate analyses and IP due diligence in medicinal chemistry, drug discovery and related biological fields. Prior to joining Reinhold Cohn she was a senior scientist in the computational chemistry department of EPIX Pharmaceuticals, working on drug optimization and in‑silico screening.
Practice areas
Intellectual PropertyPatentsLife SciencesChemistryPharmaceuticals
Office
Expertise
Medicinal ChemistryDrug Discovery & OptimizationProtein Structure AnalysisMicroscopyMolecular & Cell BiologyComputational ChemistryPatent Prosecution & Freedom to Operate (FTO)IP Due Diligence
Education
- Postdoctoral studies, Weizmann Institute of Science — investigating three-dimensional structure of proteins using cryo‑Transmission Electron Microscopy (TEM)
- Ph.D. Chemistry, 2002, Weizmann Institute of Science — analysis of tumor physiology and metabolism using Magnetic Resonance Spectroscopy (MRS), Magnetic Resonance Imaging (MRI) and cell biology techniques
Admissions
- Association of Israel Patent Attorneys
- AIPPI
Languages
HebrewEnglish